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The Dahl salt-sensitive rat is a 50-year-old enigma in hypertension research. How does salt increase blood
pressure? One hypothesis put forward is the involvement of reactive oxygen species produced in the renal
outer medulla. A novel rat gene-deletion model in this issue of Cell Metabolism supports this argument.Half a century ago, Dahl and associates
(1962) fed rats an 8% (by weight) salt
diet, measured blood pressure, and
crossed animals with the highest blood
pressures and with the lowest blood pres-
sures. The salt-sensitive (DS) rats devel-
oped severe hypertension after several
generations, while the resistant (DR) strain
did not. Dahl and many other investiga-
tors worked diligently to pursue themech-
anisms involved (Rapp, 1982). The
Guyton laboratory developed the idea
that the long-term ‘‘infinite gain’’ relation-
ship between blood pressure and salt
excretion (pressure natriuresis) is the
ultimate blood pressure regulatory mech-
anism (Coleman et al., 1971). Further
implicating the DS kidney is the fact that
the DS strain exhibits albuminuric renal
disease even when given a low-salt diet,
a state of affairs that is greatly potentiated
by high salt (Sterzel et al., 1988). Now,
Feng et al. (2012) draw attention to
a potential molecular renal mechanism.
The control strain in this report is not the
DR rat strain, but rather the Brown Nor-
way (BN) strain. The authors probably
selected the salt-resistant BN strain
because the BN rat underwent total
genome sequencing and serves as the
reference strain. The group presents
evidence that increased nicotinamide
adenine dinucleotide phosphate (NADPH)
activity in the renal outer medulla is
responsible for the salt-sensitive genetic
hypertension. The NADPH oxidase is an
enzyme complex found on the plasma
membrane and in the phagosomic
membranes of many cells and is respon-
sible for reactive oxygen species (ROS)
production. The complex consists of five
phagocytic oxidase (phox) subunits,
including the heme-containing Nox,
p22phox, p40phox, p47phox, and p67phox,
each encoded by its own gene. Fenget al. (2012) raise some strong arguments
supporting an increase in renal outer
medullary ROS production as the hyper-
tensive mechanism in DS rats.
Moreno et al. (2007), from the authors’
laboratory, had previously shown that
a congenic DS strain containing a 12.2
Mb genomic region from the BN strain
was no longer salt sensitive. The finding
implies that the segment, which contains
the gene encoding p67phox, necessarily
contains genes critical for the salt-sensi-
tive phenotype. The authors discovered
a promoter deletion in the p67phox gene
of DS rats that was not present in BN
rats. Feng et al. (2012) then used reporter
assays in transfected renal medullary
cells to show that the mutant promoter
produced increased luciferase activity.
They postulate that the deletion could
contain a not-yet-identified repressor
element. The investigators also showed
an increase in p67phox mRNA, an increase
in protein expression by western blotting,
an increase in (microdialysis-determined)
medullary ROS production, and a salt-
sensitive increase in blood pressure that
they documented by radiotelemetry in
DS rats, all compared to BN control rats.
The authors then used the zinc finger
nuclease technology to produce a 5 bp
deletion in the genomic sequence of the
DS p67phox gene. The p67phox gene-
deleted DS rats no longer had an increase
in NADPH oxidase activity, ROS produc-
tion was reduced, and most importantly,
the telemetric blood pressure increase
with high-salt diet was reduced to BN rat
levels. Finally, the renal target organ find-
ings mentioned earlier in DS rats were
diminished in the p67phox gene-deleted
rats. These observations would surely
have interested Dahl and his supporters
and detractors alike. However, are these
findings of any clinical relevance?Cell Metabolism 15Intersalt was a most exacting epidemi-
ological study of human salt intake in 52
centers of 200 subjects each worldwide
(Intersalt Cooperative Research Group,
1988). In 48 ‘‘industrialized’’ centers, the
subjects consumed about 160 mmol/day
Na+. Four centers were outside the norm
of salt intake. In these centers, the Inter-
salt investigators found very low sodium
excretion, lower blood pressures, and
little or no upward slope of blood pressure
with increasing age. Across the other 48
(industrialized) centers, sodium excretion
was significantly related to the slope of
blood pressure with age, but not to
median blood pressure or prevalence of
high blood pressure. Across centers there
was no consistent association between
electrolyte excretion and blood pressure.
A 250 g rat has about 1% of the human
body surface area and about 0.3% of the
body weight. Assuming a 20 g chow con-
sumption per day, rats ingesting the 8%
salt diet receive 1.6 g salt (28 mmol/day
Na+) daily, compared to animals receiv-
ing 0.4% salt diet ingesting 0.1 g salt
(1.8 mmol/day). The Na+ increase is
15-fold.
The Institute of Medicine (http://www.
iom.edu/Reports/2010/Strategies-to-
Reduce-Sodium-Intake-in-the-United-
States.aspx) has advocated a reduction
in U.S. adult salt consumption from the
current (Intersalt) intake level to about
100 mmol/day Na+ (0.3-fold reduction).
Therefore, the relevance of an 8% salt
diet in the rat to salt-sensitive human
hypertension is a matter of conjecture.
So why would increased ROS in the
outer renal medulla make DS rats hyper-
tensive? Blood pressure is a function of
flow and resistance; all hypertension
features an increase in peripheral vascular
resistance. The authors argue that
increased ROS at this site could increase, February 8, 2012 ª2012 Elsevier Inc. 129
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Figure 1. Arterial Blood Pressure Is a Function of Flow and
Resistance
Arterial blood pressure is a function of flow and resistance. Increased periph-
eral resistance must be reflected throughout the entire arterial tree. The infin-
ite-gain controller is the kidney that regulates salt and water in the body by
determining the pressure natriuresis relationship. Pressure natriuresis relation-
ships are conventionally shown with salt intake/excretion on the ordinate,
although salt intake is the independent and blood pressure the dependent vari-
able. In the BN/DS rat model, salt intake was increased from 0.5% to 8%chow
weight. Blood pressure increased about 30 mm Hg in DS rats, resulting in
a rightward-shifted flatter sigmoid curve in DS compared to BN. Responsible
for the shift in pressure natriuresis was an increase in reactive oxygen
produced in the outer medulla of the kidney.
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Na+K+2Cl cotransporter in
the ascending limb of Henle’s
loop (NKCC2). They further
suggest that an influx of
T cells into the kidney could
perhaps contribute directly;
indeed, immunosuppressive
treatment can ameliorate
salt-sensitive hypertension
(Harrison et al., 2011). In DS
rats, the pressure natriuresis
curve is shifted rightward
(Figure 1). In addition to outer
medullary ROS, we can add
neural inflammatory mecha-
nisms and an elaborate
macrophage-driven proteo-
glycan-Na+ storage compart-
ment (Machnik et al., 2009).
We can debate the role of
Na+, Cl, and both ions and
the importance of volume-
related effects, if any.However, the mechanisms shifting pres-
sure natriuresis are still not solved, and
the Guyton laboratory’s notion of total
body autoregulation remains imperfectly
explained.
What are the therapeutic ramifications
from this study? The authors argue that
NADPH in the kidney could be a thera-
peutic target. However, the entire
chapter of antioxidant treatments for
cardiovascular disease does not inspire130 Cell Metabolism 15, February 8, 2012 ª2confidence (Halliwell, 2000). Suffice it to
say, much work remains to be done. It
would be important to sequence the
p67phox gene promoter in the DR strain
to determine whether or not this strain
(which has been used in hundreds of
papers) is similar to the BN control.
Furthermore, the postulated regulatory
element within the deletion remains to
be defined. Dahl and his followers would
be intrigued.012 Elsevier Inc.REFERENCES
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